Life Ebitda vs Cost Of Revenue Analysis
| LABS Stock | 39.00 0.20 0.52% |
Life Science financial indicator trend analysis is infinitely more than just investigating Life Science REIT recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Life Science REIT is a good investment. Please check the relationship between Life Science Ebitda and its Cost Of Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Life Science REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Ebitda vs Cost Of Revenue
Ebitda vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Life Science REIT Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Life Science's Ebitda and Cost Of Revenue is -0.51. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Life Science REIT, assuming nothing else is changed. The correlation between historical values of Life Science's Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Life Science REIT are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Life Science's Ebitda and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | -0.51 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Ebitda
Cost Of Revenue
Cost of Revenue is found on Life Science REIT income statement and represents the costs associated with goods and services Life Science provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most indicators from Life Science's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Life Science REIT current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Life Science REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Tax Provision is likely to gain to about (138.7 K) in 2024. Selling General Administrative is likely to drop to about 5.8 M in 2024
Life Science fundamental ratios Correlations
Click cells to compare fundamentals
Life Science Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.